Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Retained Earnings (2022 - 2025)

Historic Retained Earnings for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$89.6 million.

  • CervoMed's Retained Earnings fell 3996.06% to -$89.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$89.6 million, marking a year-over-year decrease of 3996.06%. This contributed to the annual value of -$70.7 million for FY2024, which is 2992.37% down from last year.
  • As of Q3 2025, CervoMed's Retained Earnings stood at -$89.6 million, which was down 3996.06% from -$81.9 million recorded in Q2 2025.
  • CervoMed's Retained Earnings' 5-year high stood at -$52.1 million during Q3 2023, with a 5-year trough of -$141.5 million in Q3 2022.
  • Moreover, its 4-year median value for Retained Earnings was -$64.0 million (2024), whereas its average is -$78.6 million.
  • In the last 5 years, CervoMed's Retained Earnings skyrocketed by 6318.56% in 2023 and then crashed by 3996.06% in 2025.
  • Quarter analysis of 4 years shows CervoMed's Retained Earnings stood at -$52.3 million in 2022, then fell by 4.16% to -$54.4 million in 2023, then decreased by 29.92% to -$70.7 million in 2024, then fell by 26.69% to -$89.6 million in 2025.
  • Its Retained Earnings stands at -$89.6 million for Q3 2025, versus -$81.9 million for Q2 2025 and -$75.6 million for Q1 2025.